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Under ambient air conditions, NO inhibits
NMDAR activity by reacting with the NR2A sub-
unit C399 along with two additional cysteine
pairs if their disulfide bonds are reduced to
free thiol groups [NR1(C744,C798); NR2(C87,
C320)]. Here we demonstrate that relative hyp-
oxia enhances S-nitrosylation of NMDARs by
a unique mechanism involving an ‘‘NO-reactive
oxygen sensor motif’’ whose determinants in-
clude C744 andC798 of the NR1 subunit. Redox
reactions involving these two thiol groups sen-
sitize other NMDAR sites to S-nitrosylation
and consequent receptor inhibition, while their
own nitrosylation has little effect on NMDAR ac-
tivity. The crystal structure of the ligand-binding
domain of NR1 reveals a flexible disulfide bond
(C744-C798), whichmay account for its suscep-
tibility to reduction and subsequent reaction
with NO that is observed with biochemical
techniques. These thiols may be nitrosylated
preferentially during increasing hypoxia or
stroke conditions, thus preventing excessive
activity associated with cytotoxicity while
avoiding blockade of physiologically active
NMDARs.INTRODUCTION
Glutamate is the major excitatory neurotransmitter of the
central nervous system. NMDA-type glutamate receptors
have been implicated in multiple physiological processes,
including neuronal development (Akazawa et al., 1994;
Bliss and Collingridge, 1993; Lu et al., 2001; Monyer
et al., 1994), long-term potentiation (Collingridge et al.,
1983), and long-term depression (Mulkey and Malenka,
1992). However, overstimulation of NMDA receptors can
cause excessive Ca2+ influx, free radical generation, and
abnormal enzymatic activity, and can thus contribute
to a number of neurodegenerative diseases (Lipton and
Rosenberg, 1994). To date, NMDA receptor antagonists
have failed in clinical trials for stroke because of lack of
clinical tolerability arising from the blockade of normal
NMDA receptor activity (Lipton, 2004; Lipton and Chen,
2004). Here, in an effort to overcome this problem, we
present a mechanism whereby excessive NMDA receptor
activity can be preferentially abated during hypoxic/stroke
insults, but not under normal conditions.
Avariety of chemicalmodifications thatmodulateNMDA
receptor activity have been reported, including phosphor-
ylation of tyrosine (Kohr and Seeburg, 1996; Wang and
Salter, 1994) and serine/threonine residues (Omkumar
et al., 1996; Tingley et al., 1997), redox modulation of di-
sulfide bonds, and S-nitrosylation of free thiol groups
on critical cysteine residues (Choi et al., 2000; Lei et al.,
1992; Lipton et al., 1993, 1996, 2002; Sucher et al.,Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc. 53
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redox modulation of a variety of other proteins, including
Zn2+ finger transcription factors (Choi et al., 2001a;
Kroncke and Carlberg, 2000), Zn2+ repository proteins
(Aravindakumar et al., 1999; Kroncke et al., 1994; Misra
et al., 1996; Pearce et al., 2000), hemoglobin (Stamler
et al., 1997), and voltage- and ligand-gated ion channels
(Lipton et al., 2002; Choi et al., 2000, 2001b; Kim et al.,
1999; Lei et al., 1992). Redoxmodulators, including reduc-
ing (Aizenman et al., 1989, 1990, 1992; Aizenman, 1995;
Scanlon et al., 1997; Tang and Aizenman, 1993a) and
oxidizing (Gilbert et al., 1991; Kohr et al., 1994; Manzoni
et al., 1992; Tang and Aizenman, 1993b) agents, have
been shown to alter NMDA receptor activity via reaction
with cysteine residues (Choi et al., 2001b; Lipton et al.,
2002). Reducing agents, such as dithiothreitol (DTT) or
dihydrolipoic acid, potentiate NMDA-evoked currents
(Kohr and Seeburg, 1996) by promoting formation of free
thiol groups. Conversely, oxidizing agents, such as 5-50-
dithio-bis(2-nitrobenzoic acid) (DTNB) or oxidized gluta-
thione (GSSG) (Sucher and Lipton, 1991), inhibit NMDA-
evoked currents by favoring disulfide formation (Aizenman
et al., 1989). Moreover, oxidation of free thiol to disulfide
prevents other covalent reactions of sulfhydryl groups,
with, for example, NO-related species.
It is very important to note that physiological concentra-
tions of O2 in the brain are relatively low compared with
room air, in the range of 10–20 mm Hg (Erecinska and Sil-
ver, 2001), thus producing a less oxidizing environment
than ambient conditions. This relative hypoxia favors free
thiol groups over disulfide formation. Additionally, patho-
logically hypoxic conditions, such as stroke, produce a
state in vivo wherein many proteins are initially further
reduced. In this pathological situation, disulfide bond
formation is even less preferred. In regards to the NMDA
receptor, we have reported evidence from electrophysio-
logical experiments of a mixture of disulfide and free thio-
ls from two pairs of cysteine residues on the NR1 and
NR2A subunits of the receptor [NR1(C744,C798) and
NR2A(C87,C322); the ratio of disulfide to free thiol varies
depending on the chemical conditions (Aizenman et al.,
1989; Choi et al., 2000, 2001b; Lei et al., 1992; Sullivan
et al., 1994; Lipton et al., 2002)].
Previously, we reported that the endogenous NO donor,
S-nitrosocysteine (SNOC), inhibits NMDA-evoked cur-
rents via S-nitrosylation and possible disulfide bond for-
mation of critical cysteine residues of NMDA receptors
on primary cortical neurons (Lei et al., 1992; Lipton et al.,
1993; Lipton and Rosenberg, 1994) as well as NR1/
NR2A recombinant receptors (Choi et al., 2000; Lipton
et al., 2002). NO inhibition of NMDA current was abolished
by pretreatment with methanethiosulfonate derivatives
such as 2-aminoethylmethanethio-sulfonate (MTSEA) and
[2-(trimethylammonium)ethyl] methanethiosulfonate bro-
mide (MTSET), which react specifically with thiol groups
to form mixed disulfides, thus rendering thiol groups un-
available to react with NO (Kim et al., 1999). These previ-
ous experiments showed that thiol groups of cysteine resi-54 Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc.dues are crucial for S-nitrosylation of the NMDA receptor.
Furthermore, from site-directed mutagenesis studies, we
found that the cysteine residue at position #399 on the
NR2A subunit accounted for the predominant effect of
S-nitrosylation. Additionally, we found that the aforemen-
tioned two pairs of cysteines on the NR1 and NR2A sub-
units could possibly undergo S-nitrosylation or further
oxidation and thus downregulate NMDA receptor activity
if they were in the free thiol form (Choi et al., 2000,
2001b; Lipton et al., 2002). In the present study, we report
that increasing hypoxia renders the receptor exquisitely
sensitive to S-nitrosylation. This finding is reminiscent
of previous observations on the ryanodine receptor-Ca2+
release channel (RyR) (Eu et al., 2000) showing that thiol
groups are involved in O2 sensing to produce allosteric
regulation of S-nitrosylation at physiological levels of par-
tial pressure of oxygen (pO2). Moreover, the mechanism
reported here suggests that S-nitrosylation of the receptor
may be used to curtail the excessive NMDA activity that
occurs during hypoxia/stroke with relatively less effect
on normal function. Importantly, we also report here that
the C744,C798 pair of cysteine residues found on the NR1
subunit constitute a unique ‘‘molecular oxygen sensor’’ in
the brain; it controls the degree of downregulation of
NMDA receptor function by S-nitrosylation in the pres-
ence of low pO2 levels, and thus dictates the pathological
effects of hypoxia that are mediated via the receptor.
RESULTS
Relative Hypoxia Potentiates Endogenous
NO-Induced Downregulation of NMDA Receptor
Responses in Primary Cerebrocortical Neurons
Initially, we studied whether lowering oxygen tension
would affect the attenuation of NMDA receptor responses
by endogenous neuronal nitric oxide synthase (nNOS),
which we had previously observed under room air condi-
tions (Lei et al., 1992; Lipton et al., 1993, 2002; Kim et al.,
1999; Choi et al., 2000). It should be noted that, in fact,
room air conditions actually represent a form of oxidative
stress (pO2 150–160 mm Hg), but the term ‘‘ambient con-
ditions’’ is used here as a matter of convention. In these
experiments, to permit relatively long-term monitoring of
NMDA responses without rundown, we performed digital
[Ca2+]i imaging on cultured cerebrocortical neurons stim-
ulated with consecutives pulses of 50 mM NMDA under
control (ambient) and relatively hypoxic conditions. As
we previously reported (Kim et al., 1999; Choi et al.,
2000), the addition of L-arginine to the medium as a sub-
strate for NOS led to a decrease in successive NMDA
responses under room air conditions (Figure 1). This effect
reflects downregulation of NMDA receptor activity by
endogenous NO generated by nNOS in response to Ca2+
entry via NMDA receptor-operated channels. The effect
was abrogated by the NOS inhibitor L-nitro-arginine.
Under hypoxic conditions (pO2 as low as 5 mm Hg; see
Experimental Procedures), this attenuation of NMDA re-
sponses was greatly enhanced (Figure 1). In fact, L-arginine
Neuron
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sponses (60.0% decrement) as it was under control
room air conditions (29.8%). The magnitude of the inhibi-
tory effect on NMDA receptor activity in this series of
experiments was determined by comparing the difference
in response to NMDA between L-arginine-treated and
L-nitro-arginine-treated cells under relatively hypoxic
versus room air conditions. This phenomenon is patho-
physiologically relevant since we observed it at oxygen
tensions of 5 mm Hg or less, but it is also physiologically
relevant becausewecould see a smaller, but reproducible,
effect at oxygen tensions of 10–20 mm Hg, which ap-
proach those encountered in the brain.
Biotin-Switch Assay Reveals that NR1 Thiols
Are Increasingly S-Nitrosylated under
Relatively Hypoxic Conditions
We next asked if relative hypoxia could increase the de-
gree of S-nitrosylation of the NMDA receptor. Previously,
using the biotin-switch technique, Solomon Snyder’s
group had shown that cysteine thiols on the NR1 subunit
of the NMDA receptor are S-nitrosylated (Jaffrey et al.,
2001). Here, using a similar protocol, we demonstrated
that relative hypoxia enhanced S-nitrosylation of NR1
Figure 1. Hypoxia Enhances NO Inhibition of NMDA Re-
sponses in Primary Cerebrocortical Neurons
The mean of repetitive neuronal [Ca2+]i responses to 50 mM NMDA in
each of three experiments was arbitrarily designated as 100%. Addi-
tion of the nNOS substrate, L-arginine (1 mM for 30 min), resulted in
a small, but statistically significant, decrement in the NMDA response
under ambient conditions (p < 0.05). Concomitant incubation with the
nNOS inhibitor L-nitro-arginine (1 mM) not only reversed this effect, but
also resulted in increased NMDA responses compared with the control
condition (p < 0.001), probably because of the presence of endoge-
nous levels of NO under baseline conditions. Under hypoxic condi-
tions, the effect of L-arginine in decreasing the NMDA response was
significantly greater than the effect under ambient conditions (p <
0.001). Note that even under control hypoxic conditions, the effect of
endogenous NO was greater than the effect under control ambient
conditions (p < 0.001). L-nitro-arginine again reversed the effect under
hypoxic conditions. Values are mean ± SEM for n = 13–21microscopic
fields with 8–15 cortical neurons/field in three separate cultures.(Figure 2). For this purpose, we activated endogenous
nNOS under room air versus relatively hypoxic conditions
and performed a biotin-switch assay to monitor S-nitro-
sylation of NR1. We were able to compare the levels
of NR1 S-nitrosylation using a technique we recently re-
ported that normalizes the amount of S-nitrosylated pro-
tein to total protein (Uehara et al., 2006). We found that
relative hypoxia increased S-nitrosylation of the NR1 sub-
unit by approximately 2-fold (Figure 2).
To further investigate the mechanism of the enhanced
downregulation of NMDA responses by NO in the pres-
ence of relative hypoxia, we next turned to electrophysio-
logical recordings from recombinant receptors.
Hypoxia Sensitizes Recombinant NR1/NR2A
Receptor Responses to Downregulation
by S-Nitrosylation
We used the oocyte expression system to examine the
effect of hypoxia on responses of recombinant NMDA
receptors. Under room air conditions, application of the
endogenously occurring NO donor SNOC (500 mM) in-
hibited NMDA-evoked currents in oocytes expressing
NR1/NR2A subunits (by 18.8% ± 1.1%, mean ± SEM,
n = 10; Figure 3A), consistent with our previous findings
(Choi et al., 2000; Kim et al., 1999). We found that lowering
the ambient O2 tension to 10 mm Hg resulted in in-
creased inhibition of NMDA-evoked currents by NO (to
29.7% ± 6.7%, n = 10; p < 0.05 by Mann-Whitney U test;
Figures 3B and 3C). This finding is consistent with the
notion that the increased number of free thiol groups on
Figure 2. S-Nitrosylation of the NR1 Subunit of the NMDA
Receptor under Hypoxic Conditions
(A) Expression constructs for NR1 and NR2A were transfected into
nNOS-HEK cells. Twenty-four hours later, nNOS-HEK cells were
treated with 5 mM A23187 for two hours to allow Ca2+ entry to stimu-
late endogenous nNOS under ambient (room air) or hypoxic conditions
(pO2 = 5–10 mm Hg). Cell extracts were subjected to the biotin-switch
assay. SNO-NR1, S-nitrosylated NR1.
(B) Quantitative analysis of SNO-NR1 formation. Blots from the biotin-
switch assay and western analyses were quantified by densitometry,
and the relative ratio of SNO-NR1 to total NR1 was calculated. Error
bars = SEM (*p < 0.05 by ANOVA).Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc. 55
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NO-Reactive Thiol Oxygen Sensor on NMDA ReceptorsFigure 3. Hypoxia Enhances NO Inhibi-
tion of NMDA-Evoked Currents
(A) NMDA-evoked currents (200 mMNMDA and
10 mM glycine) in oocytes expressing NR1/
NR2A subunits were inhibited by application
of the NO donor SNOC (500 mM) under ambient
conditions.
(B) Hypoxia enhanced SNOC-mediated in-
hibition of NMDA current. Holding potential,
80 mV, pH 7.2.
(C) Summary of the effect of hypoxia on SNOC-
mediated inhibition of NMDA-evoked currents.
Suppression of NMDA currents by SNOC is
expressed as the normalized response to
NMDA prior to application of SNOC. Each
column represents mean ± SEM (*p < 0.05;
Mann-Whitney U test).critical cysteine residues, which are known to be present
under hypoxic conditions, may react with NO to enhance
the inhibitory effect of S-nitrosylation on the NMDA recep-
tor. Additionally, DTT not only mimicked this effect of hyp-
oxia, but also occluded further effects of hypoxia (see
Figure S1 in the Supplemental Data), suggesting hypoxia
sensitivity occurs at critical cysteines responsible for DTT
modulation (Choi et al., 2001b) and that the hypoxic condi-
tion itself was chemically reducing.
Similar to the NMDA receptor, accumulating evidence
suggests that the RyR can be poly-nitrosylated (Xu
et al., 1998); relatively hypoxic conditions can increase the
sensitivity of this reaction in an allosteric manner, allowing
lower levels of NO to be effective (Eu et al., 2000; Stamler
et al., 2001). To test this possibility for the NMDA receptor,
we performed dose-response curves for NO. Under ambi-
ent air conditions, a 10-fold lower concentration of SNOC
(50 mM) only slightly attenuated NMDA-evoked currents
(Figure 4A), compared with inhibition with 500 mM. Intrigu-
ingly, however, during hypoxia, 50 mM SNOC inhibited
the NMDA-evoked currents to a greater extent than the
same concentration of SNOC under ambient conditions
(Figure 4B). At an even lower concentration of 5 mM,SNOC
did not significantly inhibit NMDA-evoked currents under
ambient conditions (Figure 4A). Nonetheless, at a pO2
of10mmHg, 5 mMSNOCmanifested a significant inhib-
itory effect (Figures 4B and 4C). These results suggest that
the NMDA receptor becomes more sensitive to inhibition
by NO under relatively hypoxic conditions; in fact, physio-
logically relevant levels of NO inhibit NMDA receptor activ-
ity at physiological oxygen tensions.56 Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc.Cysteine 399 on the NR2A Subunit Contributes
to Enhanced NO Sensitivity under Relatively
Hypoxic Conditions
From previous electrophysiological and chemical studies,
we knew that, among other cysteine residues, C399 of
NR2A was a primary site of S-nitrosylation (Choi et al.,
2000; Kim et al., 1999; Lipton et al., 2002). We found in
the present study that under ambient air conditions, NO
manifested virtually no effect on NMDA-evoked currents
in oocytes expressing NR1/NR2A(C399A) mutant recep-
tors (Figure 5A). Additionally, we found that hypoxia-
mediated enhancement of NO inhibition of NMDA-evoked
currents was virtually eliminated in this mutant compared
with wild-type NR1/NR2A receptors (Figures 5B and 5C
versus Figures 3 and 4).
C744 and C798 on the NR1 Subunit Constitute
an Oxygen Sensor
We also knew from previous work (Sullivan et al., 1994;
Choi et al., 2000, 2001b; Kim et al., 1999; Lipton et al.,
2002) that the NR1 subunit harbors a pair of redox-active
cysteine residues that can form a disulfide bond, but can
apparently be nitrosylated if in the free thiol state. In fact,
by mutational studies, these were the only cysteine
thiols found to be redox active and S-nitrosylated on the
NR1 subunit (Sullivan et al., 1994; Choi et al., 2000,
2001b). When we expressed mutant NR1(C744A,C798A)/
NR2A receptors, NO could still significantly inhibit NMDA
responses under ambient air conditions. Remarkably,
however, hypoxic enhancement of the inhibitory effect
of NO was totally abrogated (Figure 6). Therefore, we
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NO-Reactive Thiol Oxygen Sensor on NMDA ReceptorsFigure 4. Hypoxia Shifts the Sensitivity of
NMDA Receptor Inhibition toward Lower
Concentrations of NO
(A) Inhibition of NMDA responses by SNOC
(5–500 mM) under ambient conditions.
(B) Inhibition of NMDA responses by SNOC
(5–500 mM) under hypoxic conditions. At each
concentration of SNOC, hypoxic conditions
augmented inhibition of NMDA-evoked cur-
rents greater than ambient air conditions.
Remarkably, at lower concentrations of SNOC,
inhibition of NMDA-evoked current was evident
only under hypoxic conditions.
(C) Potentiation of NMDA-evoked currents
expressed as normalized responses to NMDA
before SNOC application. Values are mean ±
SEM (n = 7 in each case). SNOC inhibition of
NMDA currents was significantly greater under
hypoxic conditions compared with ambient
conditions (*p < 0.05, **p < 0.01; Mann-Whitney
U test).concluded that, under hypoxic conditions, while not di-
rectly inhibiting NMDA receptor activity itself, S-nitrosyla-
tion of NR1(C744,C798) influenced the overall sensitivity
of receptor activity to inhibition by S-nitrosylation at other
sites.Putative Structure of the Thiol Oxygen Sensor
on NR1
The NR1(C744A,C798A) mutant abrogated NO inhibition
of NMDA receptor activity under relatively hypoxic con-
ditions. This observation was consistent with the notionNeuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc. 57
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groups located at NR1 residues C744,C798, preferentially
reacts with NO under hypoxic conditions. Therefore, we
Figure 5. Cysteine Residues of the NR2A Subunit Involved in
Hypoxic Enhancement of SNOC Inhibition
(A and B) SNOC-mediated NMDA current inhibition was abolished in
oocytes expressing NR1/NR2A(C399A). The mutant also abrogated
the enhancement of NO inhibition by hypoxia.
(C) Summary histogram of the effect of NR2A cysteine mutation at res-
idue 399 on NO-mediated NMDA receptor inhibition. Values represent
mean ± SEM of responses obtained from seven oocytes.58 Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc.investigated the crystal structure of this region of the
NR1 subunit (Furukawa and Gouaux, 2003) before and af-
ter exposure to NO.
Figures 7A–7C display the electron density (2mFo-DFc,
representing the sigma A weighted omit map) in the vicin-
ity of the three disulfide bridges within the structure of
NR1-S1S2. Two of the disulfides (C420-C454 and C436-
C455) have a well-defined density, indicative of a single
conformation. For the third disulfide (C744-C798), the
electron density is well defined for the main chain and
Cb atom, but more diffuse for the Sg atoms comprising
the disulfide bridge. Figures 7D and 7E show an Fo-Fc dif-
ference map that is the average of four or five diffraction
sets, each collected from a distinct single crystal. The
only strong features (>3 s) in the map are those flanking
the Sg atoms of the C744-C798 disulfide (peak heights,
+5s and4s). We attempted to model the structure as al-
ternate configurations of C744 or C798, either as distinct
disulfide bridges or as a mixture of free thiols and disul-
fides (Heras et al., 2004). However, we could not account
for the density satisfactorily without imposing unfavorable
geometry, raising the possibility that covalentmodification
of the cysteines was present in the crystals.
In NR1 crystals treated with SNOC (four independent
crystal structures), the only significant features in the
averaged Fo-Fc difference map occur in the vicinity of
C744,C798. The peaks are in similar positions to, but
higher than (+7s, 7s), those of the untreated crystals.
The larger difference peaks suggest that a fraction of di-
sulfides are reduced in the crystal and that the free cyste-
ine sulfurs reacted with NO. This change is reflected in the
altered crystal structure, accounting for the more positive
peaks in the difference map. The inherent disorder and/or
redox mixture at these bonds precludes further descrip-
tion at the atomic level. However, we can infer that SNOC
treatment specifically affects the C744,C798 pair and that
the data are consistent with NO-induced covalent modifi-
cation in the form of facile S-nitrosylation of at least a frac-
tion of the free thiols. This notion is further supported by
our chemical evidence of S-nitrosylation of the NR1 sub-
unit using the biotin-switch technique (Figure 2, above).
We also analyzed NO-treated NR1-S1S2 peptide by
mass spectrometry using a modification of our previously
published methods (Gu et al., 2002; Yao et al., 2004; Ue-
hara et al., 2006). The predominant species detected
were free thiol at C744 and 1/2 of a disulfide on C798
(data not shown). Interestingly, this kind of ‘‘intermediate
result’’ might have been predicted from the unusually flex-
ible disulfide bond that we saw betweenC744 andC798 in
the crystal structure of NR1-S1S2. However, we did not
observe NO on either thiol, possibly because, chemically
speaking, NO is a good leaving group. As such, NO may
not be expected to be seen by this mass spectrometry
method since the SNO-intermediate on NR1-S1S2 may
be rather ephemeral. Nonetheless, as mentioned above,
the biotin-switch assay on native NMDA receptors re-
vealed increasing S-nitrosylation of the NR1 subunit with
relative hypoxia.
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NR1 Subunit Abrogates Hypoxic En-
hancement of NO-Mediated Inhibition of
NMDA-Evoked Currents
(A and B) Voltage-clamp traces from oocytes
expressingNR1(C744A,C798A)/NR2Asubunits
under ambient air (A) and hypoxic (B) condi-
tions. SNOC produced dose-dependent inhibi-
tion of NMDA-evoked currents (200 mM NMDA
plus 10 mM glycine) under ambient air con-
ditions, but hypoxia did not enhance this in-
hibition.
(C) Inhibition of NMDA-evoked currents by NO,
expressed as normalized responses to NMDA
before SNOC application. Values are mean ±
SEM (n = 4–5 oocytes).There are several possible reasons why we might be
able to detect NO (or in this case, its biotin replacement)
on the NR1 subunit by the standard biotin-switch assay
but not by mass spectrometry. For example, salt content
and detergents must be kept to a minimum during mass
spectrometry analysis in order to obtain interpretable
spectra, while this is not as critical for the biotin-switchassay. There are also various potential explanations why
we can observe S-nitrosylation of other peptides, but not
the NMDA receptor, by mass spectrometry (Gu et al.,
2002; Yao et al., 2004; Uehara et al., 2006), such as the dif-
ferential ionization efficiency for disparate peptides during
mass spectrometry analysis. These various features could
contribute to the failure of mass spectrometry to detectNeuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc. 59
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NO-Reactive Thiol Oxygen Sensor on NMDA ReceptorsFigure 7. Crystal Structure of Critical Cysteine Residues on the NR1 Subunit of the NMDA Receptor
(A–C) Sigma A weighted omit map (2mFo-DFc at +1.0 s contour) of the three disulfide bonds in the NR1-S1S2 ligand binding domain: C420-C454 (A),
C436-C455 (B), C744-C798 (C).
(D and E) Electronic density of the oxygen sensor motif, consisting of cysteine thiol groups located at NR1 residues C744,C798 that appear to react
with NO. Mean of four untreated crystals (D); mean of five SNOC-treated crystals (E). Fo-Fc averaged electron density map of C744-C798 contoured
at ±3.0 s (gray, +; pink, ).sites of S-nitrosylation compared with the biotin-switch
assay for this molecule.
Taken together with prior work, however, we have very
solid chemical data for redox modulation by S-nitrosyla-
tion of C744 or C798 on NR1 using the biotin-switch assay
in conjunction with site-directed mutagenesis experi-
ments (Sullivan et al., 1994; Kim et al., 1999; Choi et al.,
2000; 2001b; Jaffrey et al., 2001).
DISCUSSION
In this study we have established that hypoxia enhances
NO modulation of the NMDA receptor, resulting in in-
creased attenuation of NMDA-evoked currents. Since
cysteine residues are the primary target for S-nitrosyla-
tion, the redox state of the NMDA receptor is critical to
the efficacy of NOmodulation. Under physiological condi-
tions, NMDA receptors function in the brain where pO2
levels are substantially lower than in ambient air. Thus,
our findings highlight the physiological relevance of
S-nitrosylation of the NMDA receptor. Moreover, these re-
sults suggest that under pathologically hypoxic condi-
tions, S-nitrosylation of the NMDA receptor becomes
even more important because progressively lower con-
centrations of NO inhibit excessive NMDA receptor activ-
ity. A likely explanation for the enhancement of NO inhibi-
tion of NMDA-evoked currents during hypoxia is the
increase in free thiol groups that are available to react
with NO under these conditions (Figure 8). In a reminiscent
manner, relatively hypoxic conditions favor poly-nitrosyla-
tion of the RyR (Eu et al., 2000; Stamler et al., 2001).60 Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc.Intriguingly, mutation of a pair of cysteines on the NR1
subunit (C744,C798), which are also known to formadisul-
fide bond under oxidizing conditions (Choi et al., 2000,
2001b; Lipton et al., 2002; Furukawa and Gouaux, 2003),
had little if any effect on inhibition of the NMDA response
by NO under ambient conditions. However, this mutation
completely abrogated enhancement of the effect of NO
during hypoxia. Thus, this pair of cysteines functions as
an ‘‘oxygen sensor motif’’ in that it sensitizes the NMDA
receptor to inhibition by NO under hypoxic conditions,
but has little direct effect on inhibition of receptor activity
by its own nitrosylation. One possible explanation for
this effect is that under hypoxic conditions, reaction of
the free thiols at C744 or C798 with NO exerts an allosteric
effect on the receptor that facilitates further nitrosylation
at another critical cysteine site; we know that such a site
exists at NR2A(C399) because mutation of this site abro-
gated NO inhibition of receptor activity under either ambi-
ent air or hypoxic conditions.
Structural studies are needed to prove this premise, and
we have therefore examined the electronic structure of
C744,C798 in crystals of this region of the NR1 subunit.
We found that exposure to an endogenous NO donor
changes the electronic density adjacent to the cysteine
sulfur atoms, consistent with S-nitrosylation. Furthermore,
our electrophysiological experiments suggest that such
nitrosylation is facilitated in a hypoxic environment. Hence,
taken together with the chemical evidence, obtained via
the biotin-switch technique, for enhanced S-nitrosylation
under relatively hypoxic conditions, our electrophysiolog-
ical results suggest that the NR1 thiols not only sense ox-
ygen tension, but can also be S-nitrosylated themselves.
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NO-Reactive Thiol Oxygen Sensor on NMDA ReceptorsFigure 8. Schematic Representation of
Hypoxic Enhancement of NO-Mediated
Inhibition of NMDA Receptor Activity
(A) Ambient O2 levels are significantly higher
than levels in living tissues or during hypoxic
insults, favoring disulfide formation (red line).
(B) In the presence of disulfide, NO cannot be
transferred to these cysteine residues since no
free thiol exists for reaction. S-nitrosylation can
occur on NR2A C399 (cysteine residue at left),
but only in the presence of a high concentration
of NO donor. (C) Under physiological or even
more hypoxic conditions, the relatively reduc-
ing state favors free thiol groups on the NMDA
receptor. (D) Under relatively hypoxic condi-
tions, the free thiol groups are more readily
available to react with NO to form S-nitroso-
thiol, and low concentrations of an NO donor
can effect this reaction. The reaction route that
possibly leads from S-nitrosylation to disulfide
formation of vicinal thiols [NR1(C744,C798)] re-
mains unknown, although it is likely that in this
scenario, only one of these thiols is S-nitrosy-
lated. During relative hypoxia, our hypothesis
is that NO is more likely to react with both
C744 and C798 to S-nitrosylate their thiol
groups, and under these conditions, disulfide
formationwould be blocked. Such dual S-nitro-
sylation of C744,C798 would then lead to the
increasedNO sensitivity that we have observed
experimentally at other NMDA receptor sites,
such as C399 on NR2A. Therefore, NO itself
may not be regulatory at NR1(C744,C798), but
the redox status of these cysteine residues
would exert an allosteric influence on S-nitro-
sylation of other thiol groups on the NMDA
receptor, such as C399 on NR2A.It is intriguing that the same thiols that are S-nitrosylated
may constitute the molecular O2 sensor that makes addi-
tional thiol groups more easily nitrosylated.
Whatever the exact mechanism, the present study
shows that C744,C798 can sense the oxygen environment
to render the receptor exquisitely sensitive to inhibition
by S-nitrosylation under hypoxic conditions. The data
thus provide mechanistic insight into downregulation of
NMDA receptor activity by the physiological environment.
Evolutionary pressure may have allowed the brain to
develop this mechanism as a means to curtail excitotoxic
insults caused by NMDA receptor hyperactivity (Lipton
and Rosenberg, 1994). Furthermore, under pathological
conditions such as stroke, the levels of O2 are further
depressed, making S-nitrosylation even more favorable;
thus, this reaction can contribute to neuroprotection
by limiting the influx of excessive Ca2+ through NMDA
receptor-associated channels (Choi et al., 2000; Lei
et al., 1992; Lipton et al., 1993). In fact, since the receptor
is more sensitive to inhibitory control by S-nitrosylation
during hypoxia, future therapeutic modalities could take
advantage of this mechanism. For example, drugs that
target nitrosylatable cysteine residues during stroke to
prevent NMDA receptor-mediated neurotoxicity mightavoid possible side effects because physiological synap-
tic transmission would be relatively spared.
EXPERIMENTAL PROCEDURES
Fluorescence Imaging of Neuronal [Ca2+]i in Primary
Cerebrocortical Cultures
Cerebrocortical cultures were prepared and digital [Ca2+]i imaging was
performed with standard methods as previously described (Lei et al.,
1992; Lipton et al., 1993; Kim et al., 1999; Choi et al., 2000). The
cortical cultures were loaded for 30 min at 37C with 5 mM Fura-2 ace-
toxymethylester (Fura-2-AM, Molecular Probes) in Hanks’ solution
buffered with HEPES (138 mM NaCl, 1 mM NaHCO3, 0.34 mM
Na2HPO4, 5.4 mM KCl, 0.44 mM KH2PO4, 2.5 mM CaCl2, 10 mM
HEPES, 0.01 mM glycine, and 22.2 mM glucose, adjusted to pH 7.2
with NaOH) and transferred to the recording chamber of an inverted
microscope (Zeiss Axiovert 35; 203, 0.5 NA, objective) equipped
with a Sutter DG-4 fast wavelength switcher. Pairs of images from cells
stimulated at 350 nm and 380 nm with output measured at 510 nm
were acquired every 250 ms with a cooled CCD camera (Cooke
Sensicam, PCO, Germany) controlled by SlideBook software (Intelli-
gent Imaging Innovations, Santa Monica, CA). Signals were averaged
over regions of interest (cell soma), background subtracted, and
converted into [Ca2+]i using standard methods (Grynkiewicz et al.,
1985). Fura-2 loading capacity was assessed by monitoring the fluo-
rescence output at 360 nm (isosbestic point).Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc. 61
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Subunit of the NMDA Receptor
HEK293 cells stably expressing nNOS (nNOS-HEK) were cultured in
DMEM supplemented with 10% FBS, 4 mM glutamine, 200 mg/ml
G418, 100 units/ml penicillin, and 0.1 mg/ml streptomycin. nNOS-
HEK cells were transfected using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. The bio-
tin-switch assay was performed as described (Jaffrey et al., 2001;
Uehara et al., 2006; Yao et al., 2004). In brief, cells were lysed, and
free thiols were blocked with 4 mM methyl methanethiosulfonate at
50C for 20 min. After blocking, cell extracts were precipitated with
two volumes of acetone, and resuspended in 0.15 ml of HENS buffer
(250 mM HEPES [pH 7.4], 1 mM EDTA, 0.1 mM neocuproine, 1%
SDS). Subsequently, S-nitrosylated cysteines were reduced with
1 mM ascorbate and biotinylated with 1 mM Biotin-HPDP (Pierce,
Rockford, IL) at room temperature for 1 hr. After incubation, proteins
were precipitated with acetone as described above. The biotinylated
proteins were pulled down with streptavidin-agarose and analyzed
by western blotting.
cRNA Synthesis
Templates were prepared from circular plasmid cDNA by linearizing
the 30 untranslated region with NheI (for NR1-1a), or EcoRV (for
NR2A). cRNA, which incorporates the 50 cap analog [m7G(50)P(50)G],
was transcribed from 1 mg of linearized template in vitro by T7 (for
NR1) or T3 (for NR2A) RNA polymerase according to the mMessage
mMachine protocol (Ambion). cRNA concentrations were determined
bymeasuring the optical density at 260 nm and by completing agarose
gel electrophoresis.
Preparation of Oocytes and Injection of cRNA
Xenopus laevis oocytes were prepared as previously described (Choi
and Lipton, 1999; Sullivan et al., 1994). Frog oocytes at stage V or
VI were surgically removed from the ovaries of Xenopus. Lumps
of 100 oocytes were incubated with 580 U/ml (2 mg/ml) collagenase
type I (Sigma) for 2 hr in Ca2+-free solution (82.5 mM NaCl, 2 mM KCl,
1 mM MgCl2, and 5 mM HEPES, adjusted to pH 7.5 with NaOH). After
slow agitation to remove the follicular cell layer, the oocytes were
washed extensively with Ca2+-free frog Ringer’s solution. Oocytes
were maintained at 18C in frog Ringer’s solution (96 mM NaCl,
2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES, adjusted
to pH 7.5 with NaOH) supplemented with 550 mg/l sodium pyruvate
as a carbon source and 100 mg/ml gentamicin. Twenty-four hours later,
oocytes were injected with up to ten nanograms of cRNA of each
NMDA receptor subunit using a ten microliter Drummond micro-
dispenser under visual control with a dissecting microscope.
Two-Electrode Voltage-Clamp Recording in the Oocyte
Expression System
Two to seven days after injection, oocytes were recorded in frog
Ringer’s solution under two-electrode voltage clamp at 80 mV. Re-
cordings were performed at room temperature with an Oocyte Clamp
OC-725b amplifier (Warner Instrument Corporation) using Mac Lab
version 3.5 software (AD Instruments). Voltage-sensing electrodes
had a resistance of 1–4 MU, and current-injecting electrodes had a
resistance of 0.5–1 MU. Both were filled with 3 M KCl. Oocytes were
continuously superfused with a solution containing 90 mM NaCl,
1 mM KCl, 10 mMHEPES, 1.5 mM BaCl2, and 10 mM glycine, adjusted
to pH 7.2–7.5 with NaOH (the lower pHwas used in some cases to pro-
long the life of S-nitrosothiol donors). Ba2+ was used as the divalent
cation. Drugs dissolved in frog Ringer’s solution were applied by
superfusion at a flow rate of 2 ml/min in a 100 ml chamber with an
array of pipettes similar to the ‘‘sewer pipe’’ system used in patch-
clamp recording to achieve relatively rapid solution exchange. Using
a concentration jump paradigm with Mg2+, we measured a time con-
stant of less than 3 s for complete solution exchange in the recording
chamber (Choi et al., 2001b).62 Neuron 53, 53–64, January 4, 2007 ª2007 Elsevier Inc.Hypoxic Conditions
During experiments involving digital Ca2+ imaging and electrophysio-
logical recording, relative hypoxia was maintained by continuously
bubbling a solution of 100% nitrogen gas into the recording chamber.
To ensure hypoxic conditions throughout the solution, diffusion stones
(Fisher Scientific) were used. After 15 min of hypoxic equilibration, the
O2 content of the solution was measured digitally as pO2 with an Arte-
rial BloodGas Analyzer, Stat profile pHOX plus (NOVAMedical); values
as low as 5 mm Hg could be maintained in this manner and could be
increased to 10–20 mm Hg by shortening the duration of bubbling in
nitrogen. The osmolarity and pH of the solution remained unaffected
by the bubbling procedure. For the experiments involving the biotin-
switch assay, all procedures were performed in a hypoxia chamber
(Biotrace).
Atomic Resolution Structures
NR1-S1S2 recombinant protein was expressed and purified in E. coli
as described (Furukawa and Gouaux, 2003). Briefly, Origami B (DE3)
cells harboring pET-22b(+)-NR1-S1S2 were grown and induced by
0.5 mM isopropyl-b-D-thiogalactoside. All purification steps were per-
formed at 4C. The protein was purified on a metal-chelating column,
followed by an ion exchange column. Crystals were grown at 4C by
the hanging drop vapor diffusion method by mixing NR1-S1S2 at
5 mg/ml with equal volume drops from a reservoir consisting of
20%–23% polyethylene glycol 1000, 100 mM sodium cacodylate
(pH 6.0), 100 mM lithium sulfate, and 10 mM glycine. For freezing,
the crystals were transferred to a cryo-buffer consisting of 25%–
28% polyethylene glycol 1000, 100 mM lithium sulfate, 10 mM glycine,
and 100 mM sodium cacodylate (pH 6.0) with 15%–20% glycerol for
5 min, mounted on cryo-loops, and plunged into liquid nitrogen.
S-nitrosylation of crystals was performed for 30–60 min in the cryo-
buffer supplemented with 10 mM SNOC. The crystals were cryo-
cooled. Diffraction data were collected at 110 K using a Rigaku FRE
X-ray source equipped with an RAXIS-IV image plate detector. Diffrac-
tion images were processed and scaled with the HKL package (Otwi-
nowski and Minor, 1997). The NR1 structure (pdb id: 1PB7) was used
as the starting model for refinement using CNS (Brunger et al., 1998)
and program O (Jones and Kjeldgaard, 1997). Data collection and
refinement statistics are given in Supplemental Tables S1 and S2 in
the Supplemental Data. For difference map calculations, the B values
of the Sg atoms of C744,C798were assigned the average refined value
of 31 A˚2. For map averaging, refined models were overlaid (RMS main
chain deviations of 0.1–0.2 A˚) in order to generate transformation
matrices, and data sets were truncated to 2 A˚ resolution. The average
B factors for protein atoms are very similar—21.7 A˚2 (untreated; five
data sets) and 21.9 A˚2 (SNOC-treated; four data sets).
Statistical Methods
Values are presented as mean ± SEM. To be conservative in our
assessments, no underlying assumptions were made as to whether
the data fit a normal distribution or not. Hence, significance was deter-
mined using high-stringency methods with a nonparametric test
(Mann-Whitney U test).
Supplemental Data
Supplemental Data for this article include Supplemental Figure S1 and
Tables S1 and S2, and are available online at http://www.neuron.org/
cgi/content/full/53/1/53/DC1/.
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